Do NSAIDs and Other Pain Relief Drugs Can Inhibit the Growth of Lactobacillaceae?

Pol J Microbiol. 2023 Dec 16;72(4):507-513. doi: 10.33073/pjm-2023-038. eCollection 2023 Dec 1.

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) commonly used in clinical practice may cause gastrointestinal injuries and influence the gut microbiota. This study investigated the effects of various NSAIDs and some analgesics on the viability of Lactobacillaceae strains (including probiotic strains) in vitro. It was found that diclofenac, ibuprofen, ketoprofen, dexketoprofen, flurbiprofen, and acetylsalicylic acid inhibited the growth of lactobacilli at a concentration of 0.05-3.2 mg/ml. These MICs of NSAIDs are well above therapeutic plasma concentrations achieved in humans, indicating that the tested drugs should not inhibit the growth of lactobacilli in the human digestive tract.

Keywords: Lactobacillaceae; NSAIDs; analgesics; non-antibiotics; probiotic bacteria.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal* / pharmacology
  • Diclofenac
  • Humans
  • Ibuprofen / pharmacology
  • Lactobacillaceae*
  • Pain / drug therapy

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ibuprofen
  • Diclofenac